Chesley Taft & Associates LLC Edwards Lifesciences Corp Transaction History

Chesley Taft & Associates LLC

  • $2.08 Billion
  • Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 29,254 shares of EW stock, worth $1.98 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
29,254
Previous 31,656 7.59%
Holding current value
$1.98 Million
Previous $2.92 Million 33.99%
% of portfolio
0.09%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$59.7 - $93.78 $143,399 - $225,259
-2,402 Reduced 7.59%
29,254 $1.93 Million
Q2 2024

Jul 19, 2024
BUY
$84.3 - $94.31 $93,151 - $104,212
1,105 Added 3.62%
31,656 $2.92 Million
Q1 2024

Apr 15, 2024
BUY
$72.54 - $95.56 $13,347 - $17,583
184 Added 0.61%
30,551 $2.92 Million
Q4 2023

Jan 11, 2024
SELL
$61.71 - $77.76 $4,936 - $6,220
-80 Reduced 0.26%
30,367 $2.32 Million
Q3 2023

Oct 10, 2023
SELL
$69.28 - $93.38 $78,979 - $106,453
-1,140 Reduced 3.61%
30,447 $2.11 Million
Q2 2023

Jul 17, 2023
SELL
$81.41 - $94.33 $51,288 - $59,427
-630 Reduced 1.96%
31,587 $2.98 Million
Q1 2023

Apr 11, 2023
BUY
$74.26 - $84.51 $15,594 - $17,747
210 Added 0.66%
32,217 $2.67 Million
Q4 2022

Jan 19, 2023
SELL
$68.3 - $87.44 $3,756 - $4,809
-55 Reduced 0.17%
32,007 $0
Q3 2022

Oct 13, 2022
SELL
$82.37 - $107.29 $9,884 - $12,874
-120 Reduced 0.37%
32,062 $2.65 Million
Q2 2022

Jul 07, 2022
SELL
$86.5 - $128.27 $545,382 - $808,742
-6,305 Reduced 16.38%
32,182 $3.06 Million
Q1 2022

Apr 14, 2022
SELL
$101.96 - $128.34 $303,025 - $381,426
-2,972 Reduced 7.17%
38,487 $4.65 Million
Q4 2021

Jan 05, 2022
SELL
$106.37 - $130.68 $156,895 - $192,753
-1,475 Reduced 3.44%
41,459 $5.37 Million
Q3 2021

Oct 05, 2021
SELL
$102.91 - $122.75 $208,392 - $248,568
-2,025 Reduced 4.5%
42,934 $4.86 Million
Q2 2021

Jul 07, 2021
SELL
$83.84 - $104.76 $51,142 - $63,903
-610 Reduced 1.34%
44,959 $4.66 Million
Q1 2021

Apr 06, 2021
SELL
$78.68 - $90.67 $70,025 - $80,696
-890 Reduced 1.92%
45,569 $3.91 Million
Q4 2020

Jan 11, 2021
BUY
$71.69 - $91.23 $44,806 - $57,018
625 Added 1.36%
46,459 $4.24 Million
Q3 2020

Oct 08, 2020
SELL
$67.19 - $87.44 $129,004 - $167,884
-1,920 Reduced 4.02%
45,834 $3.66 Million
Q2 2020

Jul 08, 2020
BUY
$57.54 - $76.95 $1.82 Million - $2.44 Million
31,646 Added 196.46%
47,754 $3.3 Million
Q1 2020

Apr 15, 2020
SELL
$52.41 - $81.0 $5,712 - $8,829
-109 Reduced 0.67%
16,108 $3.04 Million
Q4 2019

Jan 10, 2020
SELL
$71.7 - $82.09 $20,434 - $23,395
-285 Reduced 1.73%
16,217 $3.78 Million
Q3 2019

Oct 07, 2019
SELL
$61.55 - $75.43 $17,541 - $21,497
-285 Reduced 1.7%
16,502 $3.63 Million
Q2 2019

Jul 10, 2019
SELL
$55.74 - $64.41 $4,459 - $5,152
-80 Reduced 0.47%
16,787 $3.1 Million
Q1 2019

Apr 05, 2019
SELL
$47.89 - $64.05 $270,578 - $361,882
-5,650 Reduced 25.09%
16,867 $3.23 Million
Q4 2018

Jan 07, 2019
SELL
$46.41 - $56.94 $6,729 - $8,256
-145 Reduced 0.64%
22,517 $3.45 Million
Q3 2018

Oct 12, 2018
BUY
$45.7 - $58.03 $41,130 - $52,227
900 Added 4.14%
22,662 $3.95 Million
Q2 2018

Jul 12, 2018
SELL
$42.45 - $51.3 $14,135 - $17,082
-333 Reduced 1.51%
21,762 $3.17 Million
Q1 2018

Apr 11, 2018
BUY
$37.19 - $47.45 $1,747 - $2,230
47 Added 0.21%
22,095 $3.08 Million
Q4 2017

Jan 10, 2018
SELL
$33.79 - $39.39 $365,472 - $426,042
-10,816 Reduced 32.91%
22,048 $2.49 Million
Q3 2017

Oct 13, 2017
BUY
$36.29 - $38.83 $1.19 Million - $1.28 Million
32,864
32,864 $3.59 Million

Others Institutions Holding EW

# of Institutions
1,351
Shares Held
455M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email